Preoperative Therapy for Extremity Soft Tissue Sarcomas

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

High-risk soft tissue sarcomas (STS) are defined as large (>5 cm), intermediate/high-grade tumors and can carry a >50 % risk of death from metastases. A regimen of preoperative chemoradiation immediately addresses issues of both local control and micrometastases and should be considered for patients with high-risk STS of the extremities. While acute wound healing complications are more likely to occur, these are most always manageable and reversible, as opposed to the long-term complications associated with higher radiation doses and larger fields required for post-operative therapy. Preoperative treatment also yields potential prognostic information from pathologic treatment response, and quantitative imaging methods hold promise to detect early treatment effect. Definitive evidence of survival benefit from neoadjuvant therapy has been elusive, but a large body of experience has accumulated at dedicated centers where this approach is utilized. Whenever possible, it is imperative that patients with high-risk STS be enrolled on well-designed clinical trials. Treatment planning and administration requires a coordinated multidisciplinary approach that should be undertaken in high-volume centers with expertise in the management of sarcomas.

Original languageEnglish (US)
JournalCurrent Treatment Options in Oncology
Volume16
Issue number6
DOIs
StatePublished - Jun 16 2015

Fingerprint

Sarcoma
Extremities
Therapeutics
Neoplasm Micrometastasis
Neoadjuvant Therapy
Wound Healing
Clinical Trials
Radiation
Neoplasm Metastasis
Survival
Neoplasms

Keywords

  • Chemoradiotherapy
  • Chemotherapy
  • Neoadjuvant
  • Preoperative
  • Radiation
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Preoperative Therapy for Extremity Soft Tissue Sarcomas. / Davis, Lara; Ryan, Christopher.

In: Current Treatment Options in Oncology, Vol. 16, No. 6, 16.06.2015.

Research output: Contribution to journalArticle

@article{7298e4621f244d2f93072524c203ef12,
title = "Preoperative Therapy for Extremity Soft Tissue Sarcomas",
abstract = "High-risk soft tissue sarcomas (STS) are defined as large (>5 cm), intermediate/high-grade tumors and can carry a >50 {\%} risk of death from metastases. A regimen of preoperative chemoradiation immediately addresses issues of both local control and micrometastases and should be considered for patients with high-risk STS of the extremities. While acute wound healing complications are more likely to occur, these are most always manageable and reversible, as opposed to the long-term complications associated with higher radiation doses and larger fields required for post-operative therapy. Preoperative treatment also yields potential prognostic information from pathologic treatment response, and quantitative imaging methods hold promise to detect early treatment effect. Definitive evidence of survival benefit from neoadjuvant therapy has been elusive, but a large body of experience has accumulated at dedicated centers where this approach is utilized. Whenever possible, it is imperative that patients with high-risk STS be enrolled on well-designed clinical trials. Treatment planning and administration requires a coordinated multidisciplinary approach that should be undertaken in high-volume centers with expertise in the management of sarcomas.",
keywords = "Chemoradiotherapy, Chemotherapy, Neoadjuvant, Preoperative, Radiation, Soft tissue sarcoma",
author = "Lara Davis and Christopher Ryan",
year = "2015",
month = "6",
day = "16",
doi = "10.1007/s11864-015-0346-4",
language = "English (US)",
volume = "16",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Preoperative Therapy for Extremity Soft Tissue Sarcomas

AU - Davis, Lara

AU - Ryan, Christopher

PY - 2015/6/16

Y1 - 2015/6/16

N2 - High-risk soft tissue sarcomas (STS) are defined as large (>5 cm), intermediate/high-grade tumors and can carry a >50 % risk of death from metastases. A regimen of preoperative chemoradiation immediately addresses issues of both local control and micrometastases and should be considered for patients with high-risk STS of the extremities. While acute wound healing complications are more likely to occur, these are most always manageable and reversible, as opposed to the long-term complications associated with higher radiation doses and larger fields required for post-operative therapy. Preoperative treatment also yields potential prognostic information from pathologic treatment response, and quantitative imaging methods hold promise to detect early treatment effect. Definitive evidence of survival benefit from neoadjuvant therapy has been elusive, but a large body of experience has accumulated at dedicated centers where this approach is utilized. Whenever possible, it is imperative that patients with high-risk STS be enrolled on well-designed clinical trials. Treatment planning and administration requires a coordinated multidisciplinary approach that should be undertaken in high-volume centers with expertise in the management of sarcomas.

AB - High-risk soft tissue sarcomas (STS) are defined as large (>5 cm), intermediate/high-grade tumors and can carry a >50 % risk of death from metastases. A regimen of preoperative chemoradiation immediately addresses issues of both local control and micrometastases and should be considered for patients with high-risk STS of the extremities. While acute wound healing complications are more likely to occur, these are most always manageable and reversible, as opposed to the long-term complications associated with higher radiation doses and larger fields required for post-operative therapy. Preoperative treatment also yields potential prognostic information from pathologic treatment response, and quantitative imaging methods hold promise to detect early treatment effect. Definitive evidence of survival benefit from neoadjuvant therapy has been elusive, but a large body of experience has accumulated at dedicated centers where this approach is utilized. Whenever possible, it is imperative that patients with high-risk STS be enrolled on well-designed clinical trials. Treatment planning and administration requires a coordinated multidisciplinary approach that should be undertaken in high-volume centers with expertise in the management of sarcomas.

KW - Chemoradiotherapy

KW - Chemotherapy

KW - Neoadjuvant

KW - Preoperative

KW - Radiation

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84929146717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929146717&partnerID=8YFLogxK

U2 - 10.1007/s11864-015-0346-4

DO - 10.1007/s11864-015-0346-4

M3 - Article

C2 - 25975446

AN - SCOPUS:84929146717

VL - 16

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 6

ER -